Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Stanton R. Mehr

home / authors / stanton-r-mehr

Articles

The Intestinal Bug Hypothesis in Crohn's Disease Gets a Reboot

October 21st 2014

The Economic Costs of Crohn's Disease

October 21st 2014

Exploring the Intersection of Chronic Disease, Adherence, and Life Expectancy

October 14th 2014

Recurrence of Breast Cancer Years After the Initial Tumor

September 19th 2014

Upending of Conventional Combination Therapy in Type 2 Diabetes Mellitus

September 19th 2014

Breast Cancer Survivorship Programs: More Than a Treatment

September 19th 2014

Robotic-Assisted Surgery: A Question of Value

August 25th 2014

Can Gastric Bypass Surgery Be a Cure for Diabetes Mellitus?

Inhaled Insulin's Long Journey to Commercialization

A Patient's Opinion of Unmet Need

The How and Why of Stress, Diabetes, and the Brain

A Visit With Mark Feinglos, MD, and Richard Surwit, PhD

Increasing Access to HIV Care May Help Improve Outcomes

April 22nd 2014

Targeted Programmed Cell Death in Lung Cancer Treatment

March 19th 2014

The Link Between a Common Type of Bariatric Surgery and Increased Alcohol Use

March 17th 2014

The Continuing Evolution of Employer-Based Intervention in Diabetes Disease Management

March 17th 2014

What Is the Place of New SGLT-2 Inhibitors in Therapy and on the Formulary?

March 13th 2014

Is Medicare Ready for Oncology Clinical Pathways?

February 11th 2014

Attacking Complications to Kidney Problems in Diabetes: Atrial Fibrillation and Resistant Hypertension

January 21st 2014

Nonincretin Drugs in Later-Stage Development

January 21st 2014

New Approaches to Medicaid Expansion: Hybrid Plans Offer Alternatives for Covering More People

October 22nd 2013

The Next Frontier for the Artificial Pancreas: Payer Coverage

September 27th 2013

Sequester Forcing Chemo Treatments into Hospitals Costing Taxpayers More in the End

August 20th 2013

BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart Disease

Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MD

Searching for Clinical and Economic Value in Pancreatic Cancer

Chemoprevention in Prostate Cancer: Identifying Patients at Greatest Risk May Provide Greatest Value

Applying Accountable Care to Oncology: Developing an Oncology ACO

The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.

Value-Based Contracting for Pharmaceuticals: Getting Ready for Prime Time?

Is There a Business Case for Diabetes Disease Management?

April 11th 2013

The Complexity of Covering Off-Label Use for a Multitude of Oncology Regimens

December 7th 2012

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences
AJMC®
All rights reserved.